Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment.

Onco Targets Ther · 2012 · PMC3390993 · PMID 22787405

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

failed to reach significanceno p-value reported

32 In this mixed-patient population, ORR and median objective response (OR) correlated with a diastolic blood pressure of at least 90 mmHg, whereas PFS failed to reach significance.

also in 4,113 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.